Amdocs Company Insiders

DOX Stock  USD 90.37  0.47  0.52%   
Amdocs employs about 29 K people. The company is managed by 27 executives with a total tenure of roughly 262 years, averaging almost 9.0 years of service per executive, having 1074.07 employees per reported executive. Break down of Amdocs' management performance can provide insight into the company performance.
Eli Gelman  CEO
Director, Member of Technology and Innovation Committee, CEO of Amdocs Management Limited and President of Amdocs Management Limited
Robert Minicucci  Chairman
Independent Chairman of the Board
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

Amdocs' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Amdocs' future performance. Based on our forecasts, it is anticipated that Amdocs will maintain a workforce of slightly above 29000 employees by April 2024.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Amdocs' latest congressional trading

Congressional trading in companies like Amdocs, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Amdocs by those in governmental positions are based on the same information available to the general public.
2020-08-14Representative Lois FrankelDisposed Under $15KVerify
2019-07-18Representative Gilbert CisnerosAcquired Under $15KVerify
2018-07-17Representative Earl BlumenauerAcquired Under $15KVerify

Amdocs Management Team Effectiveness

The company has Return on Asset of 0.071 % which means that on every $100 spent on assets, it made $0.071 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1562 %, implying that it generated $0.1562 on every 100 dollars invested. Amdocs' management efficiency ratios could be used to measure how well Amdocs manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to 0.14 in 2024. Return On Assets is likely to drop to 0.06 in 2024. At this time, Amdocs' Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 307 M in 2024, whereas Total Assets are likely to drop slightly above 4.5 B in 2024.
Common Stock Shares Outstanding is likely to rise to about 144.3 M in 2024, whereas Net Income Applicable To Common Shares is likely to drop slightly above 396.4 M in 2024.

Amdocs Workforce Comparison

Amdocs is one of the top stocks in number of employees category among related companies. The total workforce of Information Technology industry is currently estimated at about 29,111. Amdocs totals roughly 29,000 in number of employees claiming about 100% of equities under Information Technology industry.

Amdocs Profit Margins

The company has Net Profit Margin of 0.11 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.15 %, which entails that for every 100 dollars of revenue, it generated $0.15 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.410.3535
Fairly Up
Pretty Stable
Net Profit Margin0.080.0996
Significantly Down
Pretty Stable
Operating Profit Margin0.150.1338
Moderately Up
Pretty Stable
Pretax Profit Margin0.110.12
Significantly Down
Pretty Stable
Return On Assets0.06260.0757
Significantly Down
Pretty Stable
Return On Equity0.06950.14
Way Down
Slightly volatile

Amdocs Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Amdocs Price Series Summation is a cross summation of Amdocs price series and its benchmark/peer.

Amdocs Notable Stakeholders

An Amdocs stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Amdocs often face trade-offs trying to please all of them. Amdocs' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Amdocs' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Joshua ShefferCEO PresidentProfile
Eli GelmanDirector, Member of Technology and Innovation Committee, CEO of Amdocs Management Limited and President of Amdocs Management LimitedProfile
Robert MinicucciIndependent Chairman of the BoardProfile
Anshoo GaurDivision President of Amdocs Devel. Center India Pvt LtdProfile
Shuky ShefferSenior Vice President and President of Customer Business Group, Amdocs Management LimitedProfile
Rajat RahejaDivision President Amdocs Development Center India Pvt. LtdProfile
Avishai SharlinGM PresidentProfile
Tamar RapaportDagimSenior Vice President and CFO of Amdocs Management LimitedProfile
Richard LeFaveIndependent DirectorProfile
John MacDonaldDirectorProfile
Zohar ZisapelIndependent DirectorProfile
Simon OlswangIndependent DirectorProfile
Giora YaronDirectorProfile
Clayton ChristensenDirectorProfile
James KahanIndependent DirectorProfile
Adrian GardnerIndependent DirectorProfile
John McLennanIndependent DirectorProfile
Julian BrodskyIndependent DirectorProfile
Elizabeth McDermonSecretary and VP of Corporate Strategy of Amdocs Inc.Profile
Darcy AntonellisHead MediaProfile
Oren MarmurHead NetworkProfile
Matthew SmithCorporate SecretaryProfile
Idit AronsohnInclusion ResponsibilityProfile
Gary MilesChief OfficerProfile
Mustafa OyumiHead StrategyProfile
Matt SmithIR Contact OfficerProfile
Anthony GoonetillekeGroup StrategyProfile

About Amdocs Management Performance

The success or failure of an entity such as Amdocs often depends on how effective the management is. Amdocs management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Amdocs management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Amdocs management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for 2024
Return On Capital Employed 0.15  0.14 
Return On Assets 0.08  0.06 
Return On Equity 0.14  0.07 
The data published in Amdocs' official financial statements usually reflect Amdocs' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Amdocs. For example, before you start analyzing numbers published by Amdocs accountants, it's critical to develop an understanding of what Amdocs' liquidity, profitability, and earnings quality are in the context of the IT Services space in which it operates.
Please note, the presentation of Amdocs' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amdocs' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Amdocs' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amdocs. Please utilize our Beneish M Score to check the likelihood of Amdocs' management manipulating its earnings.

Amdocs Workforce Analysis

Traditionally, organizations such as Amdocs use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Amdocs within its industry.

Amdocs Manpower Efficiency

Return on Amdocs Manpower

Revenue Per Employee168.5K
Revenue Per Executive181M
Net Income Per Employee18.7K
Net Income Per Executive20.1M
Working Capital Per Employee19.3K
Working Capital Per Executive20.7M
When determining whether Amdocs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amdocs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amdocs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amdocs Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Amdocs Stock analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stocks Directory
Find actively traded stocks across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.